Pharmazz
Pharmazz, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Willowbrook, Illinois, founded and led by pharmacologist Dr. Anil Gulati. The company discovers, develops and commercializes first-in-class therapeutics for critical care and neurovascular medicine, built around two lead small-molecule candidates: centhaquine (Lyfaquin), a resuscitative agent for hypovolemic shock that holds marketing authorization from the Drugs Controller General of India and is licensed to Dr. Reddy's Laboratories for the Indian market, and sovateltide (Tycamzzi), an endothelin-B receptor agonist for cerebral ischemic stroke. Additional pipeline programs target septic shock, acute kidney injury, cardiac arrest, acute spinal cord injury, hypoxic-ischemic encephalopathy and Alzheimer's disease. Pharmazz is a drug-development company, not a software vendor; its public web presence is a corporate and investor brochure site and it operates no developer program, public API, SDK or machine-readable interface.
Pharmazz is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Healthcare.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 6
The organization behind the API
Other 2
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.